Elevance Health, Inc.

For the period ended Jun 30, 2025. Filed Jul 17, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Jul 17, 2025

ELV$429.65+2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Income (Unaudited) for the and

Consolidated Statements of Income

	Three Months Ended June 30		Six Months Ended June 30
	2025	2024	2025	2024
(In millions, except per share data)
Revenues
Premiums	$41,271	$35,416	$82,158	$71,112
Product revenue	6,042	5,530	11,851	10,029
Service fees	2,108	2,277	4,177	4,355
Total operating revenue	49,421	43,223	98,186	85,496
Net investment income	486	508	1,076	973
Net losses on financial instruments	(131)	(85)	(595)	(246)
Gain on sale of business	—	240	—	240
Total revenues	49,776	43,886	98,667	86,463
Expenses
Benefit expense	36,706	30,572	72,018	61,118
Cost of products sold	5,293	4,820	10,276	8,645
Operating expense	4,997	5,066	10,297	9,952
Interest expense	341	280	685	545
Amortization of other intangible assets	147	162	302	278
Total expenses	47,484	40,900	93,578	80,538
Income before income tax expense	2,292	2,986	5,089	5,925
Income tax expense	548	685	1,161	1,375
Net income	1,744	2,301	3,928	4,550
Net income attributable to noncontrolling interests	(1)	(1)	(2)	(4)
Shareholders’ net income	$1,743	$2,300	$3,926	$4,546
Shareholders’ net income per share
Basic	$7.74	$9.91	$17.39	$19.56
Diluted	$7.72	$9.85	$17.33	$19.44
Dividends per share	$1.71	$1.63	$3.42	$3.26

-3-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.